Taken together, these results indicated that IL-13Rα2 could be exploited as a prospective receptor and PEG-PLGA nanoparticle modified with the high affinity and specificity ligand Pep-1 was a potential targeting drug delivery system for glioma treatment via improving the penetration across BTB. The gene discussed is IL13RA2; the disease is central nervous system cancer.